![OLIMPIC: a 12-month study on the criteria driving retreatment with ranibizumab in patients with visual impairment due to myopic choroidal neovascularization]()
OLIMPIC: a 12-month study on the criteria driving retreatment with ranibizumab in patients with visual impairment due to myopic choroidal neovascularizationRicci, Federico; Staurenghi, Giovanni; Varano, Monica; Eandi, Chiara; Sinibaldi, Tommaso Lupieri; Colombo, Laura; Bartezaghi, Marta; Bassanini, Stefania · Graefe's Archive for Clinical and Experimental Ophthalmology · 2019